MSA
PAHC icon

Marino Stram & Associates’s Phibro Animal Health PAHC Stock Holding History

Marino Stram & Associates’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-115
Closed -$4K – 419
2019
Q1 		$4K Buy
115
+19
+20% +$591 ﹤0.01% 423
2018
Q4 		$3K Buy
+96
New +$3.62K ﹤0.01% 428

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Marino Stram & Associates's PAHC Position: Q2 2019 in Review

Marino Stram & Associates sold out of Phibro Animal Health (PAHC) in Q2 2019, closing a stake of 115 shares — an estimated $4K sold.

Marino Stram & Associates first reported a position in PAHC in Q4 2018 and held it in 2 quarters. The position peaked at $4K in Q1 2019. 168 funds tracked by Wall St. Rank hold PAHC as of Q2 2019.

  • Marino Stram & Associates reported no remaining Phibro Animal Health position as of Q2 2019 after selling out during the quarter.
  • Marino Stram & Associates sold 115 Phibro Animal Health shares in Q2 2019, an estimated $4K.
  • Marino Stram & Associates first reported a position in Phibro Animal Health in Q4 2018 and held it in 2 quarters.
  • Marino Stram & Associates's Phibro Animal Health position peaked at $4K in Q1 2019.
  • 168 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2019.

Based on Marino Stram & Associates's 13F filing for Q2 2019, filed 19 Jul 2019.